Radius Health

Radius Health Radius Health is a biopharmaceutical company focused on developing new therapeutics for treating osteoporosis and other endocrine-mediated diseases.

Radius is a science-driven biopharmaceutical company focused on developing new therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases. Radius is committed to the research and development of new therapeutics for the large and underserved osteoporosis market. The Company's lead investigational product candidate, abaloparatide (BA058), is in development, in b

oth injection (Abaloparatide-SC) and transdermal (Abaloparatide-TD) methods of administration, for the potential prevention of fractures in post-menopausal women at risk of fracture from osteoporosis. Radius' clinical portfolio of investigational product candidates also includes a new oral agent, RAD1901, a selective estrogen receptor down-regulator/degrader, or SERD, in development at higher doses for the potential treatment of breast cancer brain metastases, and at lower doses as a selective estrogen-receptor modulator, or SERM, for the potential treatment of vasomotor symptoms such as hot flashes.

Address

950 Winter Street
Waltham, MA
02451

Website

Alerts

Be the first to know and let us send you an email when Radius Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category